Skip to main content

Table 1 Inclusion and Exclusion Criteria

From: Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN)

Inclusion criteria Exclusion criteria
• Patients receiving anthracycline or trastuzumab-based chemotherapy.
• Histologically confirmed malignancy;
• Age > 18 years, and
• No contraindication to MRI.
• Physical disability preventing exercise testing or DEXA scan;
• Psychiatric disease or disorder precluding informed consent;
• Contraindication to anti-cancer therapy, including known heart failure, cardiomyopathy, or baseline LV ejection fraction less than 50 %;
• Previous anthracycline or trastuzumab-based therapy;
• Previous radiotherapy to thorax.